Synthetic Genetics Company Codon Closes $20M in Series B VC Round

Dec 19, 2006

NEW YORK (GenomeWeb News) — Synthetic genetics company Codon Devices has pocketed $20 million in a Series B round of venture capital financing, Codon said today.

Codon CEO John Danner said the company will use the cash to develop its BioFAB production platform, which uses informatics, robotics, and sequencing technology to synthesize gene codes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Maybe Not to Eat…

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Moving From DC to KC

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Just for Fun?

Slate's Jane Hu compares some at-home genetic tests to astrology.

PLOS Has Skin Cancer Risk Scores and More This Week

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.

Menu